L 2/10
EN
Official Journal of the European Union
4.1.2023
(6)
On 23 March 2022, the Authority adopted its scientific opinion on the ‘Safety of partially defatted whole Acheta domesticus (house cricket) powder as a novel food pursuant to Regulation (EU) 2015/2283’ (9) in accordance with Article 11 of Regulation (EU) 2015/2283.
(7)
In its scientific opinion, the Authority concluded that Acheta domesticus (house cricket) partially defatted powder is safe under the proposed conditions of use and use levels.
Therefore, that scientific opinion gives sufficient grounds to establish that Acheta domesticus (house cricket) partially defatted powder when used in multigrain bread and rolls, crackers and breadsticks, cereal bars, dry pre-mixes for baked products, biscuits, dry stuffed and non-stuffed pastabased products, sauces, processed potato products, legume- and vegetable- based dishes, pizza, pasta-based products, whey powder, meat analogues, soups and soup concentrates or powders, maize flour-based snacks, beerlike beverages, chocolate confectionary, nuts and oilseeds, snacks other than chips, and meat preparations, intended for the general population, fulfils the conditions for its placing on the market in accordance with Article 12(1) of Regulation (EU) 2015/2283.
(8)
On the basis of limited published evidence on food allergy related to insects in general, which equivocally linked the consumption of Acheta domesticus to a number of anaphylaxis events and, on the basis of evidence demonstrating that Acheta domesticus contains a number of potentially allergenic proteins, the Authority concluded in the opinion that consumption of this novel food may trigger sensitisation to Acheta domesticus proteins.
The Authority recommended carrying out further research on the allergenicity of Acheta domesticus.
(9)
In order to address the Authority’s recommendation, the Commission is currently exploring the ways to carry out the necessary research on the allergenicity of Acheta domesticus.
Until the data generated by the research is assessed by the Authority, and considering that, to date, evidence directly linking the consumption of Acheta domesticus to cases of primary sensitisation and allergies is inconclusive, the Commission considers that no specific labelling requirements concerning the potential of Acheta domesticus to cause primary sensitization should be included in the Union list of authorised novel foods.
(10)
The Authority also considered in its opinion that the consumption of Acheta domesticus (house cricket) partially defatted powder may cause allergic reactions in persons that are allergic to crustaceans, molluscs and dust mites.
Furthermore, the Authority noted that additional allergens may end up in the novel food, if those allergens are present in the substrate fed to insects.
Therefore, it is appropriate that foods containing Acheta domesticus (house cricket) partially defatted powder are appropriately labelled in accordance with Article 9 of Regulation (EU) 2015/2283.
(11)
In its scientific opinion, the Authority also noted that its conclusion on the safety of the Acheta domesticus (house cricket) partially defatted powder was based on the scientific studies and data on the detailed description of the production process; the results of proximate analyses; the analytical data on contaminants; the results of the stability studies; the analytical data on microbiological parameters; and, the results of the protein digestibility studies, without which it could not have assessed the novel food and reached its conclusion.
(12)
The Commission requested the applicant to further clarify the justification provided with regard to their proprietary claim over those scientific studies and data, and to clarify their claim to an exclusive right of reference to them in accordance with Article 26(2)(b) of Regulation (EU) 2015/2283.
(13)
The applicant declared that they held proprietary and exclusive rights of reference to the scientific studies and data on the detailed description of the production process; the results of proximate analyses; the analytical data on contaminants; the results of the stability studies; the analytical data on microbiological parameters; and, the results of the protein digestibility studies, under national law at the time they submitted the application and that third parties cannot lawfully access, use or refer to those data and studies.
(9) EFSA Journal 2022;20(5):7258.